Israel Englander Kiniksa Pharmaceuticals, Ltd. Call Options Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KNSA
# of Institutions
11Shares Held
1.89MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$37.1 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$4.96 Million2.82% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$966,6170.0% of portfolio
-
Barclays PLC London, X034.8KShares$852,8580.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$734,4000.56% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $844M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...